Screening for Cognitive Disorders in Multiple Sclerosis

N/ANot Yet RecruitingNCT07030036

Centre Hospitalier de Gonesse60 enrolled

Overview

This study aims to identify cognitive problems in adults with multiple sclerosis (MS). MS can affect memory, thinking speed, and spatial skills, which may impact daily life and work. We will use simple and proven tests to check for these difficulties and see how they affect quality of life. The study will include about 60 patients followed at the neurology day hospital.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Multiple Sclerosis Cognitive Dysfunction Neuropsychological Tests Quality of Life

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients aged 18 years or older * Diagnosed with multiple sclerosis (MS) for at least 6 months according to the 2017 McDonald criteria (SFSEP) * Receiving disease-modifying treatment and followed in the neurology day hospital of CH Gonesse Exclusion Criteria: \- Under 18 years old

Locations (1)

France

Gonesse, France, France

Outcomes

Primary Outcomes

Prevalence of cognitive impairment in patients with multiple sclerosis, assessed by validated cognitive tests (CSCT, RL/RI-16, Figure de REY, HAD scale, SF-12).

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.